Tongue strength and endurance testing with the IOPI in people with oral tongue cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants will have tongue pressure and endurance measured with the Iowa Oral Performance Instrument (IOPI) by trained staff at clinical visits related to their planned primary glossectomy (types 1–3). The protocol enrolls adults who have not had prior radiation or surgery to the oral cavity and who are not feeding-tube dependent. Patients with recurrent disease, required bone resection, or subtotal/total glossectomy are excluded. Data collected will be used to better characterize lingual strength and endurance around surgical treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years old
* Scheduled to undergo primary surgery for oral tongue cancer (glossectomy types 1 to 3) using any type of closure or reconstruction

Exclusion Criteria:

* Previous radiation therapy to the oral cavity or head and neck
* Previous surgery for oral cavity cancer
* Recurrent oral cavity cancer
* Surgical requirement of extension to involve bone (mandible resection)
* Subtotal or total glossectomy
* Feeding tube dependance prior to surgery

Where it's running

• Memorial Sloan Kettering at Basking Ridge (Consent only)
  Basking Ridge, New Jersey, United States Recruiting
• Memoral Sloan Kettering Monmouth (Consent only)
  Middletown, New Jersey, United States Recruiting
• Memorial Sloan Kettering Bergen (Consent Only)
  Montvale, New Jersey, United States Recruiting
• Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only)
  Commack, New York, United States Recruiting
• Memoral Sloan Kettering Westchester (Consent only)
  Harrison, New York, United States Recruiting
• Memorial Sloan Kettering Cancer Center (All Protocol Activites)
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Louise Cunningham — Memorial Sloan Kettering Cancer Center
• Study coordinator: Louise Cunningham
• Email: cunningl@mskcc.org
• Phone: 212-639-5856

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Surgeon-performed ultrasound to guide real-time removal of oral cancer

  This will test whether surgeons using ultrasound during operations can more often remove oral cancers with clear margins in adults with T1–T3 oral squamous cell carcinoma.

  Recruiting at 3 sites Copenhagen University Hospital, Rigshospitalet · Stanford, California and 6 other locations · NCT07203911

• Rehabilitation for speech after tongue cancer surgery using a prosthesis

  This study is testing if a special mouthpiece can help people who had tongue cancer surgery speak and swallow better compared to those who don’t use it.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT02584270

• Using robotic surgery to treat tumors in the head and neck

  This study is testing if using robotic surgery to remove tumors in the mouth and throat can help patients recover faster and feel better afterwards.

  Recruiting Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT01473784

• Reducing treatment intensity for HPV-positive oropharyngeal cancer

  This study is testing if lowering radiation doses and skipping chemotherapy can still help patients with HPV-positive throat cancer live longer and feel better while reducing side effects.

  Recruiting at 2 sites Georgetown University · Washington D.C., District of Columbia and 1 other locations · NCT06902623

• EVOLVE104 for advanced bladder and other squamous cell cancers

  This will try EVOLVE104, an experimental drug, in adults with advanced or metastatic bladder or other squamous cell cancers who have already tried or cannot take standard treatments.

  Recruiting at 16 sites Phase 1 EvolveImmune United, Inc · Duarte, California and 15 other locations · NCT07217171

• Sentinel lymph node biopsy versus standard neck dissection for early-stage oral cavity cancer

  This trial tests whether removing only the sentinel lymph nodes instead of doing a full neck dissection helps people with early-stage oral cavity cancer have better neck and shoulder function while keeping cancer control the same.

  Recruiting at 88 sites Phase 2/3 NRG Oncology · Birmingham, Alabama and 106 other locations · NCT04333537

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.